Cargando…
Association between MPO-463G > A polymorphism and cancer risk: evidence from 60 case-control studies
BACKGROUND: Though a number of studies have been conducted to explore the association between myeloperoxidase (MPO)-463G > A polymorphism and cancer risk, the results remain inconsistent. Therefore, we performed a meta-analysis to derive a more systematic estimation of this relationship. METHOD:...
Autores principales: | Yang, Wen-jun, Wang, Ming-yue, Pan, Fu-ze, Shi, Chen, Cen, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539634/ https://www.ncbi.nlm.nih.gov/pubmed/28764808 http://dx.doi.org/10.1186/s12957-017-1183-7 |
Ejemplares similares
-
Association between MPO-463G > A polymorphism and chronic kidney disease: a meta-analysis
por: Qin, Jiaxuan, et al.
Publicado: (2018) -
The MPO−463G>A Polymorphism and Lung Cancer Risk: A Meta-Analysis Based on 22 Case–Control Studies
por: Yang, Jun-Ping, et al.
Publicado: (2013) -
Menopausal Status Modifies Breast Cancer Risk Associated with the Myeloperoxidase (MPO) G463A Polymorphism in Caucasian Women: A Meta-Analysis
por: Pabalan, Noel, et al.
Publicado: (2012) -
Myeloperoxidase gene-463G > A polymorphism and premature coronary artery disease
por: Zhong, Chen, et al.
Publicado: (2009) -
Myeloperoxidase Promoter Polymorphism −463G
Is Associated With More Severe Clinical Expression of Cystic
Fibrosis Pulmonary Disease
por: Reynolds, Wanda F., et al.
Publicado: (2006)